Search by Drug Name or NDC
NDC 68382-0525-06 bumetanide 0.5 mg/1 Details
bumetanide 0.5 mg/1
bumetanide is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Zydus Pharmaceuticals (USA) Inc.. The primary component is BUMETANIDE.
MedlinePlus Drug Summary
Bumetanide is used to treat edema (fluid retention; excess fluid held in body tissues) caused by various medical problems, including heart, kidney, and liver disease. Bumetanide is in a class of medications called diuretics ('water pills'). It works by causing the kidneys to get rid of unneeded water and salt from the body into the urine.
Related Packages: 68382-0525-06Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Bumetanide
Product Information
| NDC | 68382-0525 |
|---|---|
| Product ID | 68382-525_58b3bb3b-6096-42fd-aebc-c856c3050071 |
| Associated GPIs | 37200010000305 |
| GCN Sequence Number | 008221 |
| GCN Sequence Number Description | bumetanide TABLET 0.5 MG ORAL |
| HIC3 | R1M |
| HIC3 Description | LOOP DIURETICS |
| GCN | 35020 |
| HICL Sequence Number | 003664 |
| HICL Sequence Number Description | BUMETANIDE |
| Brand/Generic | Generic |
| Proprietary Name | bumetanide |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | bumetanide |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 0.5 |
| Active Ingredient Units | mg/1 |
| Substance Name | BUMETANIDE |
| Labeler Name | Zydus Pharmaceuticals (USA) Inc. |
| Pharmaceutical Class | Increased Diuresis at Loop of Henle [PE], Loop Diuretic [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA202900 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 68382-0525-06 (68382052506)
| NDC Package Code | 68382-525-06 |
|---|---|
| Billing NDC | 68382052506 |
| Package | 30 TABLET in 1 BOTTLE (68382-525-06) |
| Marketing Start Date | 2018-05-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |